Xoft raises $25M for targeted cancer treatment

Xoft, a Sunnyvale, Calif. company with an X-ray radiation treatment used for breast cancer and endometrial cancer, has raised a fifth round totaling $25 million, according to VentureWire.

The treatment uses targeting technology and tools to pinpoint the area being irradiated, limiting the damage done to the patient and allowing technicians to remain in the room.

New investor Chicago Growth Partners provided a majority of the funding, and was joined by previous investors including Easton Capital, Cutlass Capital, Maverick Capital and Sutter Hill Ventures.

Next Story: eASIC announces a 45-nanometer custom design process for smaller fish in chips
Previous Story: Elance introduces new system to manage outsourced work

Tags: deal